\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ follow\\ up\\ on\\ complicated\\ cysts\\ is\\ best\\ performed\\ at\\ 6\\ weeks\\ following\\ the\\ original\\ finding\\ to\\ ensure\\ the\\ patient\\ is\\ at\\ a\\ different\\ phase\\ of\\ the\\ menstrual\\ cycle\\.\ \(0\)\
\-\ often\\ bcps\\ can\\ be\\ perscribed\\ in\\ order\\ to\\ regulate\\ the\\ ovulation\\ cycle\\ and\\ decrease\\ the\\ likelihood\\ of\\ functional\\ or\\ hemorrhagic\\ cysts\\ on\\ followup\ \(0\)\
\-\ complex\\ cystic\\ mass\\ with\\ low\\ level\\ internal\\ echoes\\.\ \(0\)\
\-\ 7\\.8\\ cm\\ in\\ greatest\\ diameter\ \(1\)\
\-\ \\‚\\Ä\\úfishnet\\ weave\\‚\\Ä\\ù\\ pattern\\ of\\ internal\\ echoes\\.\ \(0\)\
\-\ fine\\ interdigitating\\ septations\\.\ \(0\)\
\-\ no\\ color\\ doppler\\ signal\ \(0\)\
\-\ hemmorrhagic\\ cyst\ \(0\)\
\-\ ddx\\ for\\ a\\ complex\\ or\\ large\\ adnexal\\ lesion\\:\ \(0\)\
\-\ 1\\.\\ \\ hemmorrhagic\\ ovarian\\ cyst\ \(0\)\
\-\ 2\\.\\ \\ endometrioma\ \(0\)\
\-\ 3\\.\\ \\ ectopic\\ pregnancy\\ \\(\\ \\+hcg\\,\\ no\\ intrauterine\\ pregnancy\\)\ \(0\)\
\-\ 4\\.\\ \\ ovarian\\ tumors\ \(0\)\
\-\ \\ \\ \\ \\ \\ epithelial\\ tumors\\ \\-\\ cystadenoma\\,\\ cystadenocarcinoma\ \(1\)\
\-\ \\ \\ \\ \\ \\ germ\\ cell\\ tumor\\ \\-\\ teratomas\\ or\\ \\"dermoids\\"\ \(1\)\
\-\ 5\\.\\ \\ abscess\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ tubo\\ ovarian\\ abscess\\ secondary\\ to\\ pid\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ appendicitis\ \(0\)\
\-\ \\ \\ \\ \\ \\ \\ divertticulitis\ \(0\)\
\-\ 6\\.\\ \\ hydrosalpinx\\/pyosalpinx\\ \\(pid\\)\ \(0\)\
\-\ g4\\,\\ p313\\ with\\ documented\\ right\\ ovarian\\ cyst\\ from\\ outside\\ hospital\\ measuring\\ 6\\ x\\ 5\\ cm\\ admitted\\ with\\ persistent\\ worsening\\ pain\\.\ \(0\)\
\-\ hemorrhagic\\ cysts\\ are\\ included\\ in\\ the\\ differential\\ diagnosis\\ for\\ a\\ complex\\ cyst\\ which\\ includes\\:\\ functioning\\ and\\ nonfunctioning\\ hemorrhagic\\ cyst\\,\\ endometrioma\\,\\ dermoid\\,\\ torsion\\,\\ abscess\\,\\ pyo\\/hydrosalpix\\,\\ and\\ cystic\\ neoplasms\\ \\(both\\ benign\\ and\\ malignant\\)\\.\ \(0\)\
\-\ all\\ cystic\\ lesions\\ should\\ be\\ evaluted\\ for\\ malignant\\ features\\ such\\ as\\ wall\\ thickness\\,\\ inner\\ wall\\ structure\\,\\ septa\\ and\\ echogenicity\\.\\ \\ \ \(0\)\
\-\ hemorrhagic\\ cysts\\ are\\ variable\\ in\\ presentation\\ but\\ findings\\ which\\ favor\\ this\\ diagnosis\\ is\\ absence\\ of\\ internal\\ flow\\,\\ good\\ through\\ transmission\\,\\ and\\ reticular\\ fishnet\\ weave\\ pattern\\.\\ \\ if\\ sonographic\\ findings\\ are\\ not\\ strongly\\ favorable\\ for\\ malignancy\\,\\ follow\\-up\\ in\\ 1\\-2\\ menstrual\\ cycles\\ is\\ indicated\\ as\\ most\\ hemorrhagic\\ cysts\\ resolve\\ in\\ this\\ time\\ period\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ hemorrhagic\\:\\ 0\\.06995095941516136\ \(0\)\
\-\ weave\\:\\ 0\\.061863287185729816\ \(0\)\
\-\ hemmorrhagic\\:\\ 0\\.061863287185729816\ \(0\)\
\-\ cysts\\:\\ 0\\.05872733829528713\ \(0\)\
\-\ fishnet\\:\\ 0\\.056999096444958264\ \(0\)\
\-\ ovarian\\:\\ 0\\.054880612568815\ \(0\)\
\-\ pid\\:\\ 0\\.046444167344773885\ \(0\)\
\-\ cyst\\:\\ 0\\.04028721291273864\ \(0\)\
\-\ echoes\\:\\ 0\\.03985981900377087\ \(0\)\
\-\ menstrual\\:\\ 0\\.03956115504293721\ \(0\)\
\-\ cycle\\:\\ 0\\.03927468490595296\ \(0\)\
\-\ endometrioma\\:\\ 0\\.036913476227909366\ \(0\)\
\-\ bcps\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ perscribed\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ \\-fine\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ tubo\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ divertticulitis\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ hydrosalpinx\\/pyosalpinx\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ g4\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ p313\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ pyo\\/hydrosalpix\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ evaluted\\:\\ 0\\.030931643592864908\ \(0\)\
\-\ internal\\:\\ 0\\.03015658811977654\ \(0\)\
\-\ regulate\\:\\ 0\\.028499548222479132\ \(0\)\
\-\ ovulation\\:\\ 0\\.028499548222479132\ \(0\)\
\-\ interdigitating\\:\\ 0\\.028499548222479132\ \(0\)\
\-\ \\+hcg\\:\\ 0\\.028499548222479132\ \(0\)\
\-\ abscess\\:\\ 0\\.028440381517202813\ \(0\)\
\-\ \\-complex\\:\\ 0\\.027076863632625923\ \(0\)\
\-\ cystic\\:\\ 0\\.025943502181597456\ \(0\)\
\-\ pregnancy\\:\\ 0\\.025781437666412898\ \(0\)\
\-\ nonfunctioning\\:\\ 0\\.02464476826224015\ \(0\)\
\-\ complex\\:\\ 0\\.024013269316590435\ \(0\)\
\-\ dermoids\\:\\ 0\\.023635357481707586\ \(0\)\
\-\ 7\\.8\\:\\ 0\\.023222083672386942\ \(0\)\
\-\ pattern\\:\\ 0\\.02292240237944757\ \(0\)\
\-\ tumors\\:\\ 0\\.022524325316985973\ \(0\)\
\-\ malignant\\:\\ 0\\.021674881939503867\ \(0\)\
\-\ cycles\\:\\ 0\\.02167179331351312\ \(0\)\
\-\ \\-no\\:\\ 0\\.021203262111321813\ \(0\)\
\-\ teratomas\\:\\ 0\\.020789988302001173\ \(0\)\
\-\ septa\\:\\ 0\\.020789988302001173\ \(0\)\
\-\ favor\\:\\ 0\\.020600278753684413\ \(0\)\
\-\ transmission\\:\\ 0\\.020600278753684413\ \(0\)\
\-\ cystadenocarcinoma\\:\\ 0\\.02024910872365991\ \(0\)\
\-\ functioning\\:\\ 0\\.019499725915596546\ \(0\)\
\-\ reticular\\:\\ 0\\.019499725915596546\ \(0\)\
\-\ favorable\\:\\ 0\\.019499725915596546\ \(0\)\
\-\ \\-\\:\\ 0\\.01928135219693014\ \(0\)\
\-\ intrauterine\\:\\ 0\\.018997617692295937\ \(0\)\
\-\ likelihood\\:\\ 0\\.018663196008771994\ \(0\)\
\-\ septations\\:\\ 0\\.018357892931615397\ \(0\)\
\-\ epithelial\\:\\ 0\\.018261756180078154\ \(0\)\
\-\ documented\\:\\ 0\\.017988206911763373\ \(0\)\
\-\ 6\\:\\ 0\\.017909615167542976\ \(0\)\
\-\ original\\:\\ 0\\.017901566165832248\ \(0\)\
\-\ resolve\\:\\ 0\\.01773445020446644\ \(0\)\
\-\ ensure\\:\\ 0\\.0174223537623033\ \(0\)\
\-\ cystadenoma\\:\\ 0\\.0174223537623033\ \(0\)\
\-\ wall\\:\\ 0\\.01736953768588594\ \(0\)\
\-\ 1\\-2\\:\\ 0\\.01720524708259071\ \(0\)\
\-\ torsion\\:\\ 0\\.016745498793445432\ \(0\)\
\-\ strongly\\:\\ 0\\.016684475134807294\ \(0\)\
\-\ greatest\\:\\ 0\\.016565522321910168\ \(0\)\
\-\ adnexal\\:\\ 0\\.016565522321910168\ \(0\)\
\-\ functional\\:\\ 0\\.016507524771204166\ \(0\)\
\-\ inner\\:\\ 0\\.01612635339926453\ \(0\)\
\-\ echogenicity\\:\\ 0\\.01612635339926453\ \(0\)\
\-\ cm\\:\\ 0\\.01608390258117183\ \(0\)\
\-\ variable\\:\\ 0\\.015974872094474325\ \(0\)\
\-\ ddx\\:\\ 0\\.015829660809692378\ \(0\)\
\-\ complicated\\:\\ 0\\.015556111541377602\ \(0\)\
\-\ germ\\:\\ 0\\.01551252375190898\ \(0\)\
\-\ thickness\\:\\ 0\\.015469470795446473\ \(0\)\
\-\ neoplasms\\:\\ 0\\.015261790544954086\ \(0\)\
\-\ order\\:\\ 0\\.015027785722151727\ \(0\)\
\-\ different\\:\\ 0\\.01484403840454711\ \(0\)\
\-\ color\\:\\ 0\\.014635535174825003\ \(0\)\
\-\ 6\\.\\:\\ 0\\.014568699402998006\ \(0\)\
\-\ sonographic\\:\\ 0\\.014535752945630146\ \(0\)\
\-\ doppler\\:\\ 0\\.014503112971376415\ \(0\)\
\-\ ectopic\\:\\ 0\\.014375507202355801\ \(0\)\
\-\ followup\\:\\ 0\\.014313403423059659\ \(0\)\
\-\ phase\\:\\ 0\\.014104308345157043\ \(0\)\
\-\ period\\:\\ 0\\.014018374941619163\ \(0\)\
\-\ included\\:\\ 0\\.013825688072860866\ \(0\)\
\-\ diagnosis\\:\\ 0\\.013769960216002946\ \(0\)\
\-\ decrease\\:\\ 0\\.01372015314220375\ \(0\)\
\-\ dermoid\\:\\ 0\\.013668552625046924\ \(0\)\
\-\ appendicitis\\:\\ 0\\.01364303417126068\ \(0\)\
\-\ structure\\:\\ 0\\.013617699967844935\ \(0\)\
\-\ \\,\\:\\ 0\\.013298038306112363\ \(0\)\
\-\ indicated\\:\\ 0\\.012973770566841205\ \(0\)\
\-\ admitted\\:\\ 0\\.012952822612502593\ \(0\)\
\-\ 5\\.\\:\\ 0\\.012931998979099737\ \(0\)\
\-\ good\\:\\ 0\\.012829695174568313\ \(0\)\
\-\ findings\\:\\ 0\\.012763767970455857\ \(0\)\
\-\ features\\:\\ 0\\.012652744810965184\ \(0\)\
\-\ best\\:\\ 0\\.012614605610133943\ \(0\)\
\-\ diameter\\:\\ 0\\.012614605610133943\ \(0\)\
\-\ outside\\:\\ 0\\.012576876516182146\ \(0\)\
\-\ absence\\:\\ 0\\.012466063982672325\ \(0\)\
\-\ are\\:\\ 0\\.012261830237153703\ \(0\)\
\-\ includes\\:\\ 0\\.01208729963452223\ \(0\)\
\-\ measuring\\:\\ 0\\.011990721833153493\ \(0\)\
\-\ persistent\\:\\ 0\\.011959111061425894\ \(0\)\
\-\ 4\\.\\:\\ 0\\.01180519287859929\ \(0\)\
\-\ worsening\\:\\ 0\\.01180519287859929\ \(0\)\
\-\ malignancy\\:\\ 0\\.011586279571233388\ \(0\)\
\-\ hospital\\:\\ 0\\.011288057771817976\ \(0\)\
\-\ \\‚\\Ä\\ú\\:\\ 0\\.011198248834312842\ \(0\)\
\-\ which\\:\\ 0\\.011193997103456482\ \(0\)\
\-\ \\‚\\Ä\\ù\\:\\ 0\\.011135478431678543\ \(0\)\
\-\ n\\/a\\:\\ 0\\.010860374201259952\ \(0\)\
\-\ or\\:\\ 0\\.010542344725933763\ \(0\)\
\-\ benign\\:\\ 0\\.010347545147484916\ \(0\)\
\-\ presentation\\:\\ 0\\.010327721524530114\ \(0\)\
\-\ 3\\.\\:\\ 0\\.01025920776189729\ \(0\)\
\-\ for\\:\\ 0\\.01023309682305565\ \(0\)\
\-\ flow\\:\\ 0\\.00990896097143339\ \(0\)\
\-\ x\\:\\ 0\\.009891460825780622\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.009754515759444709\ \(0\)\
\-\ finding\\:\\ 0\\.009663373701889409\ \(0\)\
\-\ often\\:\\ 0\\.00956657385445492\ \(0\)\
\-\ should\\:\\ 0\\.009558626462767719\ \(0\)\
\-\ 2\\.\\:\\ 0\\.009534891725614942\ \(0\)\
\-\ follow\\:\\ 0\\.009527015691040119\ \(0\)\
\-\ differential\\:\\ 0\\.00951915729597519\ \(0\)\
\-\ such\\:\\ 0\\.009373097508213517\ \(0\)\
\-\ 1\\.\\:\\ 0\\.009365576022096846\ \(0\)\
\-\ be\\:\\ 0\\.009247415602413538\ \(0\)\
\-\ as\\:\\ 0\\.009070719339607914\ \(0\)\
\-\ in\\:\\ 0\\.008871520634531683\ \(0\)\
\-\ 5\\:\\ 0\\.008772492710330398\ \(0\)\
\-\ level\\:\\ 0\\.008641715886480463\ \(0\)\
\-\ through\\:\\ 0\\.008515638661125854\ \(0\)\
\-\ weeks\\:\\ 0\\.008509746515442626\ \(0\)\
\-\ following\\:\\ 0\\.008509746515442626\ \(0\)\
\-\ all\\:\\ 0\\.008480433296250143\ \(0\)\
\-\ time\\:\\ 0\\.008468776235927412\ \(0\)\
\-\ secondary\\:\\ 0\\.008382561285995816\ \(0\)\
\-\ performed\\:\\ 0\\.008359923969218664\ \(0\)\
\-\ low\\:\\ 0\\.008337431764443508\ \(0\)\
\-\ if\\:\\ 0\\.00813594187291451\ \(0\)\
\-\ at\\:\\ 0\\.008124653704081636\ \(0\)\
\-\ cell\\:\\ 0\\.00809909021607539\ \(0\)\
\-\ up\\:\\ 0\\.008062621582646397\ \(0\)\
\-\ lesions\\:\\ 0\\.008026528092434905\ \(0\)\
\-\ \\:\\:\\ 0\\.007931753094671333\ \(0\)\
\-\ signal\\:\\ 0\\.0079055239658694\ \(0\)\
\-\ is\\:\\ 0\\.007891800398382115\ \(0\)\
\-\ both\\:\\ 0\\.007656842072582882\ \(0\)\
\-\ \\(\\:\\ 0\\.0076038076446722155\ \(0\)\
\-\ \\)\\:\\ 0\\.0075109230748768956\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.007368894868883569\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.007227191235025414\ \(0\)\
\-\ tumor\\:\\ 0\\.006990288777581794\ \(0\)\
\-\ most\\:\\ 0\\.006922228567466934\ \(0\)\
\-\ can\\:\\ 0\\.006800780184101999\ \(0\)\
\-\ this\\:\\ 0\\.006744822549572864\ \(0\)\
\-\ large\\:\\ 0\\.006556289234495017\ \(0\)\
\-\ but\\:\\ 0\\.00639474842467908\ \(0\)\
\-\ lesion\\:\\ 0\\.006107211319299841\ \(0\)\
\-\ on\\:\\ 0\\.005079936928880197\ \(0\)\
\-\ to\\:\\ 0\\.0044954537730840655\ \(0\)\
\-\ from\\:\\ 0\\.00444363408124285\ \(0\)\
\-\ not\\:\\ 0\\.004332697093831352\ \(0\)\
\-\ a\\:\\ 0\\.004174734755985276\ \(0\)\
\-\ mass\\:\\ 0\\.004170038620868647\ \(0\)\
\-\ and\\:\\ 0\\.00378966327857302\ \(0\)\
\-\ pain\\:\\ 0\\.0036617830439674903\ \(0\)\
\-\ right\\:\\ 0\\.0031636200319663742\ \(0\)\
\-\ no\\:\\ 0\\.0030191022831712352\ \(0\)\
\-\ patient\\:\\ 0\\.003005585722513642\ \(0\)\
\-\ the\\:\\ 0\\.0029105112569184377\ \(0\)\
\-\ of\\:\\ 0\\.0016351410638314166\ \(0\)\
\-\ with\\:\\ 0\\.0012316229062093657\ \(0\)\
\-\ \\.\\:\\ 0\\.0011210379820214614\ \(0\)\
